Cynthia Smith joined the Dicerna board of directors in 2018. Ms. Smith has more than 20 years of leadership experience in the healthcare industry. Most recently she served as Chief Commercial Officer and a member of the executive team of ZS Pharma (acquired by AstraZeneca). There, she led efforts to transition the company from the development stage to a commercial enterprise.
Prior to joining ZS Pharma, Ms. Smith served as Vice President, Market Access and Commercial Development at Affymax, Inc. Earlier, she held various senior leadership positions in market access, corporate strategy, government relations and external affairs at Merck & Co. Before beginning her career in the biopharmaceutical industry, Ms. Smith served as a healthcare policy analyst in the White House Office of Management and Budget. She previously served on the board of Nivalis Therapeutics.